ArticleJAMA neurology2014
Secondary prevention trials in Alzheimer disease: the challenge of identifying a meaningful end point.
Richard J KryscioPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
this paperpooled ittrialcites it